Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (6717)	4/9/1998 9:30:00 AM
From: david	Read Replies (2) \| Respond to of 23519

looks like bid and ask are up a little bit now: bid: 9 11/16 ask 9 3/4

To: VLAD who wrote (6717)	4/9/1998 9:59:00 AM
From: RT	Read Replies (2) \| Respond to of 23519

VLAD, I'm glad to see Vivus repurchased 1.6 m shares. This at least sends a strong message that management is confident in the company. Now, if only the street would regain confidence in them. One other positive note is that the new facility is non contract labor and highly automated, and this will result in a substantial savings. As to be expected, Vivus is still waiting for the FDA inspectors to show up and inspect the new plant. Typical government agency, slow and inefficient. The conference call was cut short and my questions were never answered, plus Nina never returned my call. RT

To: VLAD who wrote (6717)	4/9/1998 11:16:00 AM
From: 4 - Bob	Read Replies (1) \| Respond to of 23519

VLAD, What do you make of the following paragraph taken from the business wire indicated below: VIVUS Reports First Quarter Results BusinessWire, Thursday, April 09, 1998 at 07:47 MOUNTAIN VIEW, Calif.--(BW HealthWire)--April 9, 1998--VIVUS Inc ... Also, during the quarter, VIVUS received Food and Drug Administration (FDA) approval of the finished packaging area contained within its new facility located in Lakewood, New Jersey. Approval of this operations area will allow the Company to transfer the final packaging of US commercial product from the current contract facilities to high speed, automated equipment in the new plant. This efficiency should result in cost savings to the Company. ... The paragraph state that Vivus "RECEIVED" FDA approval during the quarter. Could this be a typo or are there more than one pending FDA approval for the new plant and/or its operations? Live long & Prosper, 4-BOB